{"transactions":[{"id":3034559,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":146710,"kind":"person","name":"Waclawski Anthony","position":1,"cik":"0001823486","reported_name":"Waclawski Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-10T20:07:46.000Z","date":"2020-09-08","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares shall vest in full on the one year anniversary of the date of grant."}],"balance_after":80000,"derivative":{"exercise_price":12.58,"expiration_date":"2030-09-08","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001104659-20-103943","document":"tm2030582d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465920103943/tm2030582d1_4.xml","form_type":"4"}},{"id":3034558,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":146710,"kind":"person","name":"Waclawski Anthony","position":1,"cik":"0001823486","reported_name":"Waclawski Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-09-10T20:07:46.000Z","date":"2020-09-08","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded effective on September 8, 2020 under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock vest in full on July 1, 2021, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001104659-20-103943","document":"tm2030582d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465920103943/tm2030582d1_4.xml","form_type":"4"}}]}